Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Fundraising
Biotech
Fierce Biotech Fundraising Tracker: F2G, Candid & more
Welcome to Fierce Biotech's Fundraising Tracker, 2024's version.
Gabrielle Masson
,
Annalee Armstrong
,
Darren Incorvaia
,
Max Bayer
Sep 12, 2024 8:00am
Candid flashes big ambitions with $370M debut
Sep 9, 2024 9:00am
Biopharma Q2 VC hit highest level since ’22, while M&A slowed
Aug 23, 2024 4:00am
8 months after $213M fundraise, gene editor Tome cuts costs
Aug 22, 2024 2:57pm
venBio raises $528M for fifth life sciences VC fund
Aug 1, 2024 12:30pm
Cardio-focused Cardurion raises hearty $260M series B
Jul 16, 2024 3:47pm
